ID
45503
Description
Principal Investigator: Geoffrey Ginsburg, MD, PhD, Institute for Genome Science and Policy, Duke University, Durham, NC, USA MeSH: Cardiovascular Diseases,Myocardial Infarction,Coronary Artery Disease https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000551 Case control cohort: The details have been previously published: American Heart Journal. 2010;160:371-379 e372. Briefly, a nested case:control cohort of CATHGEN participants who had experienced death or MI (n = 250) after their index catheterization and age-, sex-, and race-matched controls (n = 250) who were free of death/MI 2 years after cardiac catheterization was identified as part of the MURDOCK Horizon 1 Cardiovascular Disease Study.21 Sufficient RNA for microarray analysis was available in 447 members of this cohort. Observational cohort: 224 sequential CATHGEN samples were selected for whole blood RNA analysis, of which, 191 had sufficient RNA for microarray analysis.
Link
Keywords
Versions (2)
- 11/3/22 11/3/22 - Simon Heim
- 12/13/22 12/13/22 - Kristina Keller
Copyright Holder
Geoffrey Ginsburg, MD, PhD, Institute for Genome Science and Policy, Duke University, Durham, NC, USA
Uploaded on
December 13, 2022
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000551 Gene expression in CAD
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID and sample ID of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Sample ID, source of biologic sample, and analyte type of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID and sample ID of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Subject ID, age, sex, race, history or transplantation, days from catheterization to death, death or myocardial infraction, coronary artery disease, hyperlipidemia, hypertension, smoking, and diabetes of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
- Sample ID, source of biologic sample, and analyte type of participants with or without myocardial infraction or coronary artery disease and involved in the "Gene Expression Signatures in CATHGEN" project.
C0679823 (UMLS CUI [1,2])
C1711176 (UMLS CUI [1,3])
C1608383 (UMLS CUI [1,4])
C5420592 (UMLS CUI [1,5])
C4288536 (UMLS CUI [1,6])
C0000872 (UMLS CUI [1,7])
C0030705 (UMLS CUI [1,8])
C1442880 (UMLS CUI [1,9])
C0018795 (UMLS CUI [1,10])